Nephroprotective potential of glucagon-like peptide-1 receptor agonists
Patients with diabetes mellitus (DM), which is a key factor in the development of kidney diseases, are increasingly competing for limited healthcare resources. Diabetic kidney disease (DKD) remains a significant cause of end-stage renal failure in the patients of many countries and is also associate...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d917d0f44dee4e3b8116df39d5037ef2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|